4.8 Article

DDIT4 Licenses Only Healthy Cells to Proliferate During Injury-induced Metaplasia

Journal

GASTROENTEROLOGY
Volume 160, Issue 1, Pages 260-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2020.09.016

Keywords

Regeneration; IFRD1; Gamma-H2Ax; Cyclical Hit Model

Funding

  1. AITAC of the Washington University Digestive Disease Center [DDRCC: P30 DK052574]
  2. National Institutes of Health (NIH) [S10 RR0227552]
  3. NIH, NIDDK [T32-DK077653]
  4. National Key R&D Program of China [MOST2017YFC0908300]
  5. National Natural Science Foundation of China [81961128026, U1908207]
  6. Major Scientific and Technological Special Project of Liaoning Province of China [2019020176-JH1/103]
  7. Overseas training project of Liaoning general higher education [2019GJWYB022]
  8. Alvin J. Siteman Cancer Center-Barnes-Jewish Hospital Foundation Cancer Frontier Fund
  9. NIH National Cancer Institute [P30 CA091842, R01 CA246208]
  10. Barnard Trust
  11. NIGMS, NIH [R25-GM103757]
  12. [R01DK094989]
  13. [R01DK105129]
  14. [R01DK110406]
  15. [R01CA239645]

Ask authors/readers for more resources

The study reveals that high expression of DDIT4 in gastric chief cells decreases as cells become metaplastic. DDIT4 deficiency leads to increased mTORC1 levels, exacerbating mitosis of metaplastic cells and tumor formation.
In stomach, metaplasia can arise from differentiated chief cells that become mitotic via paligenosis, a stepwise program. In paligenosis, mitosis initiation requires reactivation of the cellular energy hub mTORC1 after initial mTORC1 suppression by DNA damage induced transcript 4 ( DDIT4 aka REDD1). Here, we use DDIT4-deficient mice and human cells to study how metaplasia increases tumorigenesis risk. METHODS: A tissue microarray of human gastric tissue specimens was analyzed by immunohistochemistry for DDIT4. C57BL/6 mice were administered combinations of intraperitoneal injections of high-dose tamoxifen (TAM) to induce spasmolytic polypeptide-expressing metaplasia (SPEM) and rapamycin to block mTORC1 activity, and N-methyl-N-nitrosourea (MNU) in drinking water to induce spontaneous gastric tumors. Stomachs were analyzed for proliferation, DNA damage, and tumor formation. CRISPR/Cas9-generated DDIT4(-/-) and control human gastric cells were analyzed for growth in vitro and in xenografts with and without 5-fluorouracil (5-FU) treatment. RESULTS: DDIT4 was expressed in normal gastric chief cells in mice and humans and decreased as chief cells became metaplastic. Paligenotic Ddit4(-/-) chief cells maintained constitutively high mTORC1, causing increased mitosis of metaplastic cells despite DNA damage. Lower DDIT4 expression correlated with longer survival of patients with gastric cancer. 5-FU-treated DDIT4(-/-) human gastric epithelial cells had significantly increased cells entering mitosis despite DNA damage and increased proliferation in vitro and in xenografts. MNU-treated Ddit4(-/-) mice had increased spontaneous tumorigenesis after multiple rounds of paligenosis induced by TAM. CONCLUSIONS: During injury-induced metaplastic proliferation, failure of licensing mTORC1 reactivation correlates with increased proliferation of cells harboring DNA damage, as well as increased tumor formation and growth in mice and humans.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available